ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technology.
ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technologies. The company is driven by a mission to save lives from cancer by giving people early diagnosis when cancer can be cured. Its genetic test is based on the analysis of free-circulating DNA in blood plasma and fluid biopsy technologies, enabling doctors to do early diagnosis and treatment initiation for cancer.The company was founded in 2013 and is headquartered in Moscow City.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 21, 2020 | Series A | $3.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Iskra Ventures | — | Series A |